ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1714

Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 Signaling

Gaochan Wang1, Qingfu Xu2, Stacey Duemmel1 and Benjamin Korman1, 1University of Rochester, Rochester, NY, 2University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2023

Keywords: Bioinformatics, Monocytes/macrophages, pulmonary, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1713–1733) RA – Animal Models Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pulmonary hypertension (PH) is a severe, progressive disorder characterized by elevated pulmonary artery pressures, right ventricular hypertrophy, and increased mortality. We previously demonstrated that TNF-transgenic (TNF-Tg) mice develop a severe PH phenotype and that deficiency of TNFR1 reversed this pathology. To explore the roles of immune cells contributing to PAH in TNF-Tg mouse model, we assessed single-cell RNA expression of immune cells in TNF-Tg mice crossed with mice lacking TNFR1 or TNFR2.Because we saw dramatic shifts in myeloid populations, we focused on characterizing the abnormal monocytes and macrophages present in TNF lungs.

Methods: TNF-Tg mice were crossed with mice deficient in either TNFR1(TNFR1KO) or TNFR2 (TNFR2KO). Lungs from wild type, TNF-Tg, TNF-Tg-TNFR1KO and TNF-Tg-TNFR2KO mice (n = 5–6) at 4.5 months of age were harvested and digested to a single cell suspension for single cell RNA sequencing (scRNAseq). The library was prepared using 10X Genomics Chromium instrument and sequencing was performed on Illumina NovaSeq6000. scRNAseq reads were examined for quality and mapped to reference mouse genome. The resulting scRNAseq data was analyzed with Seurat v.4.9. Differential expression and pathways analysis were performed and visualized using Seurat and R packages enrichR and Enhanced Volcano.

Results: Cells were clustered based on their expression profiles and cell types were annotated based on established cell markers from Lung Map and the published literature. A total of 40 clusters were identified, corresponding to 5 major cell groups (Fig 1.A-B): epithelial (Epcam+), endothelial (Pecam1+), mesenchymal (Col1a1+), lymphoid (Ptprc+), and myeloid (Ptprc+ and Fcer1g+). We observed dramatic changes in cellular composition of myeloid cells between WT and TNF-Tg, and TNF-Tg_TNFR1-KO and TNF-Tg_TNFR2-KO. We focused on myeloid cells and re-clustered these cells to identify 7 myeloid cell types (2 monocytes subsets, 4 macrophage subsets, neutrophils, and dendritic cells) were identified (Fig 2.A-B). Among the myeloid cells, monocytes and macrophages account for the dramatic changes in cellular composition. Moreover, WT and TNF-Tg-TNFR1KO mice shared the similar cellular composition, and TNF-Tg and TNF-Tg-TNFR2KO mice shared the similar cellular composition (Fig 2.D), which was consistent with the whole cellular composition in 4 mouse groups and lung histology (Fig 2.C). We next performed differential expression analysis in monocytes and macrophages (Fig 3. A-D). In monocytes, interferon responses and complement signaling were significantly differentially expressed in both TNF-Tg and TNF-Tg_TNFR2-KO mice. In macrophages, a majority of pathways related to TNF-mediated NK-kB signaling pathways and JAK/STAT signaling in TNF-Tg and TNF-Tg_TNFR2-KO mice (Fig 3. E-H).

Conclusion: Overexpression of TNF results in significant shifts in cellular composition of pulmonary myeloid cells. TNFR1 signaling is primarily responsible for these changes. Pathway analysis suggests that lung monocyte-mediated interferon responses contribute to the pathogenesis of PH.

Supporting image 1

Figure 1. Cellular composition of major cell types in mouse lung. A. UMAP projection of all scRNA-seq data, showing 5 major cell groups that were identified. B. Feature plots identifying canonical markers of epithelial (Epcam), endothelial (Pecam1), mesenchymal (Col1a1), myeloid (Ptprc, Fcer1g) and lymphoid (Ptprc+, Fcer1g-) cells populations.

Supporting image 2

Figure 2. Cellular composition of myeloid cells identified in mouse lung from TNF-Tg and TNF receptor deficient mice. A. A total of eight clusters of myeloid cells were identified from mice across all genotypes. Cell populations are colored as indicated by legend. B. Feature plots showing expression of principal identifiers of different myeloid cell types. C. Lung histology images demonstrated that TNF-Tg and TNF-Tg_TNFR2-KO mice, but not WT and TNF-Tg_TNFR1-KO mice have pulmonary inflammation and vascular occlusion. D. UMAP plots myeloid subsets in TNF-Tg mice with and without TNF receptor deficiency. Cell populations are colored as indicated by legend. E. Proportion of myeloid subsets across genotypes.

Supporting image 3

Figure 3. Differential expression (DE) analysis of genes and pathways in monocytes and macrophages. A-B. Volcano plot showing the differentially expressed genes in monocytes and macrophage between TNF-Tg and WT mice. C-D. Volcano plot showing the differentially expressed genes in monocytes and macrophage between TNF-Tg_TNFR2-KO and TNF-Tg_TNFR1-KO mice. E-F. Pathway analysis in monocytes. G-H. Pathway analysis in macrophages. MSigDB_Hallmark_2020 database was used for analysis. Dot plots identify pathways in descending significance of p-value (dot size) and odds-ration (color).


Disclosures: G. Wang: None; Q. Xu: None; S. Duemmel: None; B. Korman: Teneofour, Inc, 2.

To cite this abstract in AMA style:

Wang G, Xu Q, Duemmel S, Korman B. Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 Signaling [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/aberrant-myeloid-populations-in-the-tnf-transgenic-model-of-pulmonary-hypertension-overexpress-interferon-pathways-and-are-driven-by-tnfr1-signaling/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aberrant-myeloid-populations-in-the-tnf-transgenic-model-of-pulmonary-hypertension-overexpress-interferon-pathways-and-are-driven-by-tnfr1-signaling/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology